Although TNF-α, IL-17, and IL-23 inhibitors have fewer opportunistic infections in non-HIV patients12, meta-analyses have ostensibly shown some rates of reactivation in HIV using biologic therapies [13]. Here, IL17A is linked to Opportunistic infection.